U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. PROVENGE (sipuleucel-T)
  1. Cellular & Gene Therapy Products

PROVENGE (sipuleucel-T)

STN:  BL 125197
Proper Name: sipuleucel-T
Tradename: PROVENGE 
Manufacturer: Dendreon Corporation

Indication:

  • For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. 

Product Information

Supporting Documents

Related Information

Back to Top